Rik J. Deitsch - 15 Nov 2021 Form 5 Insider Report for NUTRA PHARMA CORP

Role
President, CEO, Director
Signature
/s/ Rik J. Deitsch
Issuer symbol
NPHC on OTC
Transactions as of
15 Nov 2021
Net transactions value
$0
Form type
5
Filing time
14 Jan 2022, 16:16:41 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPHC Series B Preferred Stock Purchase +3,000,000 3,000,000 15 Nov 2021 Direct F1, F2
transaction NPHC Series B Preferred Stock Purchase +9,000,000 +300% 12,000,000 15 Nov 2021 Direct F1, F3
holding NPHC Common Stock 43,298,859 15 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Series B preferred stock have no right of conversion to shares of common stock. Each share of Series B preferred stock is entitled to vote with the Corporation's common stock as a single class on all matters submitted to common stock holders to vote. Each share of Series B Preferred Stock is entitled to one thousand votes per share.
F2 3,000,000 shares of Series A Preferred Stock held by Mr. Deitsch were exchanged for an equal number of Series B Preferred Stock of the Company pursuant to a share exchange agreement between Rik Deitsch and the Company.
F3 9,000,000 shares of Series B Preferred Stock were issued in satisfaction of corporate debt owed by the Company to Mr. Deitsch pursuant to a resolution adopted by the board of directors of the Company.